• Most Popular
  • Most Shared

STOCKS NEWS UK SMALL-Plethora rises on trial result

Fri Nov 7, 2008 4:17am EST

Stocks

   

STOCKS NEWS Reuters Results diary

Europe [STXNEWS/EU] Real-time Equity News [E] [GB/EQUITY]

UK [STXNEWS/UK] Stocks on the move [HOT-RTRS]

UK smallcaps [STX/UKSC]

09:15GMT 07Nov2008-Plethora rises on trial result

-------------------------------------------------

Shares in urology specialist Plethora Solutions (PLE.L) rise 55 percent to 24 pence following a positive Phase III result for its premature ejaculation drug.

"The timing wasn't expected although I would say that a positive result was expected," says Edison analyst Jacob Plieth. "There was a huge sell off last week so the stock plummeted so it's kind of come back to where it was."

For more double click on [ID:nnWLB3045], for statement [ID:nnRnsG6712H].

Reuters Messaging rm://ben.deighton.reuters.com@reuters.net

08:49GMT 07Nov2008-Rentokil up after solid Q3 results

-----------------------------------------------------

Shares in Rentokil Initial (RTO.L) rise 4 percent to 48.75 pence after the services group reports slightly better than expected third quarter results and says its turnaround plans are on-track and should take three or four years to complete.

The company, founded in the 1920s, is still suffering from the poor integration of acquisitions and misguided cost-cutting plans by previous management.

"The results were a touch better than our expectations with the over-riding message that the broken businesses were on their way to being fixed, with the possible exception of UK washrooms," says Seymour Pierce analyst Kevin Lapwood.

For more, click on [ID:nL7070002]

Reuters Messaging rm://rhysl.jones.thomsonreuters.com@reuters.net

08:47GMT 07Nov2008-UK Small Caps gain 0.2 pct early

---------------------------------------------------

Britain's FTSE Small Cap index .FTSC gains 0.2 percent, underperforming blue chips .FTSE and mid caps .FTMC, both up 1.7 percent.

The FTSE Developed European Small Cap index .FTDEUSC is 1.2 percent higher, while the FTSEurofirst 300 .FTEU3 adds nearly 1 percent.

BTG (BGC.L) climbs 4.4 percent as the biotech company says it is in line for up to $307 million after licensing out a preclinical cancer drug to U.S.-based Onyx Pharmaceuticals (ONXX.O).

Model trains and Corgi models group Hornby (HRN.L) falls 7.2 percent after the company reports a 33 percent drop in half-time profits to 1.8 million pounds and warns that retail markets have become more challenging.

Reuters Messaging rm://tricia.wright.reuters.com@reuters.net

08:31GMT 07Nov2008-BTG rises on Onyx deal

----------------------------------------

British biotech company BTG (BGC.L) (BGC.L) rises 5 percent after announcing that it is in line for up to $307 million after licensing out a preclinical cancer drug to US based Onyx Pharmaceuticals (ONXX.O).

"They've got a lot of money for a preclinical drug ... the deal is very financially attractive although we are also getting more information on the Varisolve trial," says an analyst.

For more click on [ID:nL7690656], company statements [ID:nRnsG6823H] and [ID:nRnsG6824H]

Reuters Messaging rm://ben.deighton.reuters.com@reuters.net

08:22GMT 07Nov2008-Hornby falls on H1 profits slump

---------------------------------------------------

Shares in Hornby Plc (HRN.L), the model trains and Corgi models group, fall 7.2 percent to 122 pence after it reports a 33 percent drop in half-time profits to 1.8 million pounds and warns that retail markets have become more challenging.

Brokers WH Ireland says current consensus estimates of about 8 million pounds for 2008/09 now look "overly optimistic" and that the challenge to margins and volumes would pertain in the second half of the year. "Accordingly, we expect to see downgrades put through and we would recommend avoiding the shares at present," the broker added.

For more click on [ID:nL6473477]; company statement [ID:nRn1G6727H]

malcolm.locke@thomsonreuters.com; +44 207 542 0964

06:35GMT 07Nov2008-Corporate agenda for Friday

----------------------------------------------

BRITISH AIRWAYS (BAY.L) H1/TRAFFIC

DECHRA PHARMA DEPC.L AGM

GALLIFORD TRY (GFRD.L) AGM

HORNBY (HRN.L) H1

LOK'N STORE (LOK.L) YEAR

RENTOKIL INITIAL (RTO.L) Q3 TRADING

ROBERT WISEMAN (RWD.L) H1

STANELCO (SEO.L) TRADING

Reuters Messaging rm://paul.sandle.reuters.com@reuters.net



More from Reuters

A Greenpeace activist dressed as one of the "Four Horsemen of the Apocalypse" rides outside the parliament building during a brief protest in Copenhagen December 13, 2009.   REUTERS/Christian Charisius

The face of climate protest

Protesters around the globe called for an end to global warming as climate talks in Copenhagen entered their sixth day.  Video 

    In this photo reviewed by the U.S. Military, a guard leans on a fencepost as a Guantanamo detainee (L) jogs inside the exercise yard at Camp 5 detention center, at the U.S. Naval Base in Guantanamo Bay, January 21, 2009.  REUTERS/Brennan Linsley/Pool

    Life after Guantanamo

    Critics are worried that Gitmo prisoners once dubbed "enemy combatants" will be using prisons as pulpits for anti-American rhetoric once they're moved to U.S. soil.  Full Article 

    Lockheed Martin Chief Executive Robert Stevens answers a question during the Reuters Aerospace and Defense Summit in Washington December 14, 2009.  REUTERS/Molly Riley

    Lockheed eyes deals

    The future demands of cybersecurity make that sector one of many the aerospace giant sees as an acquisition target in the coming year.  Full Article